MEDICATION USE AND ADHERENCE

PUBLICATIONS

Medication Adherence and Persistence in Patients with Severe Major Depressive Disorder with Psychotic Features: Antidepressant and Second-Generation Antipsychotic Therapy versus Antidepressant Monotherapy
           Authors: Kim-Romo DN, Rascati KL, Richards KM, Ford KC, Wilson JP, Beretvas SN
           Journal of Managed Care & Specialty Pharmacy 2016;22(5):588-596

Examining Time to Initiation of Biologic Disease-Modifying Antirheumatic Drugs and Medication Adherence and Persistence among Texas Medicaid Recipients with Rheumatoid Arthritis
           Authors: Kim G, Barner JC, Rascati K, Richards K
           Clinical Therapeutics 2016;38(3):646-654

Asthma Controller Medication Adherence, Risk of Exacerbation and Use of Rescue Agents among Texas Medicaid Patients with Persistent Asthma
           Authors: Makhinova T, Barner JC, Richards KM, Rascati KL
           Journal of Managed Care & Specialty Pharmacy 2015;21(12):1124-1132

Adherence to Oral Diabetes Medications among Users and Nonusers of Antipsychotic Medication 
           Authors: Desai PR, Adeyemi AO, Richards KM, Lawson KA
           Psychiatric Services 2014;65(2):215-220

Adherence and Persistence to Prescribed Medication Therapy among Medicare Part D Beneficiaries on Dialysis: Comparisons of Benefit Type and Benefit Phase 
           Authors: Park H, Rascati K, Lawson KA, Barner JC, Richards KM, Malone DC
           Journal of Managed Care Pharmacy 2014;20(8):862-876

PRESENTATIONS

Treatment Patterns in Attention Deficit Hyperactivity Disorder among Texas Medicaid Preschoolers
           Authors: Singh RR, Lawson KA, Barner JC, Richards KM, Sasane R, Wilson JP
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Washington, DC; May 2016

Assessing Factors Associated with Antipsychotic Polypharmacy in the Texas Medicaid Population
           Authors: Desai P, Lawson KA, Richards KM, Rascati KL, Barner JC, Miller A
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Washington, DC; May 2016

Treatment Patterns of Antiepileptic Drugs in Patients with Potential Refractory Epilepsy in the Texas Medicaid Program
           Authors: Gupte-Singh K, Wilson JP, Barner JC, Hovinga CA, Rascati KL, Richards KM
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Washington, DC; May 2016

Disease-modifying Therapy Utilization among Medicaid Patients with Multiple Sclerosis
           Authors: Richards KM, Lawson KA, Nazareth T, Zhou H, Burton E, Yu T-C, Sasane R
           Consortium of Multiple Sclerosis Centers; Indianapolis, IN; May 2015

Incidence of Antipsychotic Polypharmacy in the Texas Medicaid Population
           Authors: Desai P, Lawson KA, Richards KM, Rascati KL, Barner JC, Miller A
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Montreal, Canada; June 2014

Poor Adherence to HCV Medication in a Medicaid Population
           Authors: Kim YA, Nguyen M, Richards KM, Wilson JP, Rascati KL
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Montreal, Canada; June 2014

Long-Term Controller Medication Adherence and Use of Short-Acting β2-Agonists (SABA) and Oral Corticosteroids (OCS) among Texas Medicaid Patients with Persistent Asthma
           Authors: Makhinova T, Barner JC, Richards KM, Rascati K
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Montreal, Canada; June 2014

Adherence to Oral Anti-diabetic Medications in Antipsychotic Medication Users and Non-Users
           Authors: Desai P, Adeyemi A, Richards K, Lawson K
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; New Orleans, LA; May 2013


Facebook link iconMake a Gift
Texas Pharmacy: The University of Texas at Austin College of Pharmacy